Literature DB >> 3119942

Morphological observations in skeletal muscle from patients with a mitochondrial myopathy.

A M Stadhouders1, R C Sengers.   

Abstract

Mitochondrial metabolic dysfunction is considered to be the cause of certain congenital myopathies and a number of multisystem disorders in humans. The morphological hallmark of these diseases is the 'ragged red' fibre, which shows abnormally intensive oxidative enzyme reactions. Electron microscopy reveals that the numerically increased mitochondria in these fibres are often markedly enlarged and possess aberrant configurations of cristae. The mitochondrial matrix often contains lipid-like inclusions or shows vacuolation. The most characteristic mitochondrial abnormality is the occurrence of highly ordered inclusions in the intracristal or intermembrane space. These inclusions appear to be true crystals, composed of proteinaceous material. It is argued that the activity of accumulation of proteins in the mitochondria is related to the nuclear and nucleolar hypertrophy noticeable in the ragged red fibres. Since protein crystals in mitochondria in particular occur when an increased capillary density around the ragged red fibres is present, it is suggested that oxygen free radicals and lipid peroxidation processes are involved in the ragged red fibre pathology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119942     DOI: 10.1007/bf01812848

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  Electron cytochemistry of crystalline inclusions in human skeletal muscle mitochondria.

Authors:  E Bonilla; D L Schotland; S DiMauro; B Aldover
Journal:  J Ultrastruct Res       Date:  1975-06

2.  [Ultrastructure and topochemistry of giant mitochondria and their inclusions in myopathies].

Authors:  E Sluga; A Monneron
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

3.  Mitochondria with loosely and tightly coupled oxidative phosphorylation in skeletal muscle.

Authors:  W C Hulsmann; J W de Jong; A van Tol
Journal:  Biochim Biophys Acta       Date:  1968-08-20

4.  Histochemical and ultrastructural analysis of the mitochondrial changes in a familial mitochondrial myopathy.

Authors:  S Tassin; G F Walter; J M Brucher; J J Rousseau
Journal:  Neuropathol Appl Neurobiol       Date:  1980 Sep-Oct       Impact factor: 8.090

Review 5.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

6.  Chronic progressive external ophthalmoplegia (CPEO): clinical, morphologic, and biochemical studies.

Authors:  H Mitsumoto; J R Aprille; S H Wray; R Nemni; W G Bradley
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

7.  Populations of rat skeletal muscle mitochondria after exercise and immobilization.

Authors:  D A Krieger; C A Tate; J McMillin-Wood; F W Booth
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-01

8.  The occurrence of paracrystalline mitochondrial inclusions in normal human skeletal muscle.

Authors:  F Hammersen; A Gidlöf; J Larsson; D H Lewis
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

9.  Treatment of Kearns-Sayre syndrome with coenzyme Q10.

Authors:  S Ogasahara; Y Nishikawa; S Yorifuji; F Soga; Y Nakamura; M Takahashi; S Hashimoto; N Kono; S Tarui
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

10.  A mitochondrial myopathy with a defective respiratory chain and carnitine deficiency.

Authors:  R C Sengers; J C Fischer; J M Trijbels; W Ruitenbeek; A M Stadhouders; H J ter Laak; H H Jaspar
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

View more
  15 in total

1.  Mitochondrial genome: defects, disease, and evolution.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

Review 2.  Secondary mitochondrial pathology.

Authors:  R C Sengers; A M Stadhouders
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Adult-onset mitochondrial myopathy.

Authors:  J Fernandez-Sola; J Casademont; J M Grau; F Graus; F Cardellach; E Pedrol; A Urbano-Marquez
Journal:  Postgrad Med J       Date:  1992-03       Impact factor: 2.401

4.  Histomorphologic and ultrastructural recovery of myopathy in rats treated with low-level laser therapy.

Authors:  Natalia Servetto; David Cremonezzi; Juan Carlos Simes; Antonio Di Pietro; Vilma R Campana
Journal:  Lasers Med Sci       Date:  2017-03-09       Impact factor: 3.161

5.  Absence of cytochrome c oxidase activity in a boy with dysfunction of renal tubules, brain and muscle.

Authors:  A M Das; S Schweitzer-Krantz; D J Byrd; J Brodehl
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

6.  Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies.

Authors:  A M Stadhouders; P H Jap; H P Winkler; H M Eppenberger; T Wallimann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Increased capillaries in mitochondrial myopathy: implications for the regulation of oxygen delivery.

Authors:  Tanja Taivassalo; Karen Ayyad; Ronald G Haller
Journal:  Brain       Date:  2012-01-09       Impact factor: 13.501

Review 8.  Presentation and diagnosis of mitochondrial disorders in children.

Authors:  Mary Kay Koenig
Journal:  Pediatr Neurol       Date:  2008-05       Impact factor: 3.372

9.  Confocal scanning laser microscopy of mitochondria: a possible tool in the diagnosis of mitochondrial disorders.

Authors:  M H Ruiters; E A van Spronsen; O H Skjeldal; P Stromme; H R Scholte; H Pzyrembel; G P Smit; W Ruitenbeek; E Agsteribbe
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

10.  Morphology of the mitochondria in heat shock protein 60 deficient fibroblasts from mitochondrial myopathy patients. Effects of stress conditions.

Authors:  A Huckriede; A Heikema; K Sjollema; P Briones; E Agsteribbe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.